as on December 24, 2025 at 4:01 pm IST
Day's Low
Day's High
5.22%
Downside
4.68%
Upside
52 Week's Low
52 Week's High
51.51%
Downside
33.14%
Upside
as on December 24, 2025 at 4:01 pm IST
Market Cap
₹14.51 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.38
P/B Ratio
-22.63
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-106.67
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Neutral
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Venmax Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 14.51 | 64.16% | 0.00 | -1 | NA | |
| NA | 149.32 | -6.53% | 0.00 | 9 | 118 | |
| NA | 71.39 | 15.41% | 0.00 | 7 | 285 | |
| NA | 99.93 | 1.68% | 0.00 | 6 | 57 | |
| NA | 348.22 | -4.21% | 0.66 | 12 | 379 |
Get share price movements and forecasts by analysts on Venmax Drugs & Pharmaceuticals Ltd.
Source: S&P Global Market Intelligence
Search interest for Venmax Drugs & Pharmaceuticals Ltd Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venmax Drugs & Pharmaceuticals Ltd.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 106.67% since last year same period to ₹0.02Cr in the Q2 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -50% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, Venmax Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 1 year, Venmax Drugs stock has moved up by 86.3%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 23.14% of holdings in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 76.87% to 76.87% in Sep 2025 quarter
| Organisation | Venmax Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Venmax Drugs & Pharmaceuticals Ltd share price today stands at ₹27.76 as on at the close of the market. Venmax Drugs & Pharmaceuticals Ltd share today touched a day high of ₹29.06 and a low of ₹26.31.
Venmax Drugs & Pharmaceuticals Ltd touched a 52 week high of ₹36.96 and a 52 week low of ₹13.46. Venmax Drugs & Pharmaceuticals Ltd share price today i.e. is closed at ₹27.76, which is -24.89% down from its 52 week high and 106.24% up from its 52 week low.
Venmax Drugs & Pharmaceuticals Ltd market capitalisation is ₹14.51 Cr as on .
To buy Venmax Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:
Venmax Drugs & Pharmaceuticals Ltd trading volume is 2,369.00 as on . This means that 2,369.00 shares of Venmax Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.